Literature DB >> 22618456

Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images.

Norihide Yoneda1, Osamu Matsui, Azusa Kitao, Ryuuichi Kita, Kazuto Kozaka, Wataru Koda, Satoshi Kobayashi, Toshifumi Gabata, Hiroko Ikeda, Yasunori Sato, Yasuni Nakanuma.   

Abstract

PURPOSE: Our aim was to evaluate the hepatocyte transporters in focal nodular hyperplasia (FNH) and FNH-like lesions and to correlate the grade of its expression with signal intensity on the hepatobiliary phase (HB phase) of gadoxetic-acid-enhanced magnetic resonance imaging (EOB-MRI).
MATERIALS AND METHODS: Thirteen histopathological confirmed cases including eight with EOB-MRI were studied. Immunohistochemical staining for transporter was performed and its grade semiquantitatively analyzed.
RESULTS: Histopathologically, ten cases showed almost equal organic anion transporter polypeptide (OATP) 8 expression relative to the surrounding liver; the remaining three showed stronger OATP8 expression. In eight cases with EOB-MRI, two demonstrated more hyperintensity on the HB phase, and their OATP8 expression was stronger compared with the surrounding liver. The remaining six cases showed isointensity on the HB phase and revealed almost equal OATP8 expression. The expression of export transporter multi-drug-resistant proteins (MRP) 1 and 2 were almost equal relative to the surrounding liver in most cases (11/12, 92 %; 11/12, 92 %, respectively), whereas MRP3 focally overexpressed in 75 % (9/12) of cases.
CONCLUSION: FNH and FNH-like nodules revealed equal or stronger OATP8 expression than background liver. OATP8 expression showed significant correlation with signal intensity on the HB phase.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22618456     DOI: 10.1007/s11604-012-0085-4

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  28 in total

1.  CT of focal nodular hyperplasia of the liver.

Authors:  S K Carlson; C D Johnson; C E Bender; T J Welch
Journal:  AJR Am J Roentgenol       Date:  2000-03       Impact factor: 3.959

Review 2.  Diagnosis of focal nodular hyperplasia: not so easy.

Authors:  P Bioulac-Sage; C Balabaud; I R Wanless
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

3.  Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients.

Authors:  G Brancatelli; M P Federle; L Grazioli; A Blachar; M S Peterson; L Thaete
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

Review 4.  Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update.

Authors:  P Bioulac-Sage; C Balabaud; P Bedossa; J Y Scoazec; L Chiche; A P Dhillon; L Ferrell; V Paradis; T Roskams; V Vilgrain; I R Wanless; J Zucman-Rossi
Journal:  J Hepatol       Date:  2007-01-02       Impact factor: 25.083

5.  Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver.

Authors:  Sara Vander Borght; Louis Libbrecht; Hans Blokzijl; Klaas Nico Faber; Han Moshage; Raymond Aerts; Werner Van Steenbergen; Peter L Jansen; Valeer J Desmet; Tania A Roskams
Journal:  J Pathol       Date:  2005-12       Impact factor: 7.996

6.  Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

Authors:  Kazuhiro Saito; Fumio Kotake; Naoki Ito; Taizo Ozuki; Ryuji Mikami; Kimihiko Abe; Yoko Shimazaki
Journal:  Magn Reson Med Sci       Date:  2005       Impact factor: 2.471

7.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

8.  Focal nodular hyperplasia-like areas in cirrhosis.

Authors:  A Quaglia; J Tibballs; A Grasso; N Prasad; P Nozza; S E Davies; A K Burroughs; A Watkinson; A P Dhillon
Journal:  Histopathology       Date:  2003-01       Impact factor: 5.087

9.  Adenomatous hyperplasia of the liver resembling focal nodular hyperplasia in patients with chronic liver disease.

Authors:  T Terada; S Kitani; K Ueda; Y Nakanuma; K Kitagawa; S Masuda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 10.  Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

Authors:  Peter Reimer; Günter Schneider; Wolfgang Schima
Journal:  Eur Radiol       Date:  2004-02-25       Impact factor: 5.315

View more
  16 in total

1.  Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience.

Authors:  Christian Grieser; Ingo G Steffen; Incken-Birthe Kramme; Hendrik Bläker; Ergin Kilic; Carmen Maria Perez Fernandez; Daniel Seehofer; Eckart Schott; Bernd Hamm; Timm Denecke
Journal:  Eur Radiol       Date:  2014-06       Impact factor: 5.315

2.  Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.

Authors:  Kazuto Kozaka; Satoshi Kobayashi; Norihide Yoneda; Azusa Kitao; Kotaro Yoshida; Dai Inoue; Takahiro Ogi; Wataru Koda; Yasunori Sato; Toshifumi Gabata; Osamu Matsui
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

Review 3.  Hepatocyte-specific contrast media: not so simple.

Authors:  Andrew T Trout; Alexander J Towbin; Ethan A Smith; Anita Gupta; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-08-04

Review 4.  Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?

Authors:  Yang Shin Park; Chang Hee Lee; Jeong Woo Kim; Sora Shin; Cheol Min Park
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 5.  Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.

Authors:  Maarten G Thomeer; Mirelle E E Bröker; Quido de Lussanet; Katharina Biermann; Roy S Dwarkasing; Rob de Man; Jan N Ijzermans; Marianne de Vries
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

6.  Intrahepatic periportal high intensity on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI: imaging findings and prevalence in various hepatobiliary diseases.

Authors:  Satoshi Kobayashi; Osamu Matsui; Toshifumi Gabata; Wataru Koda; Tetsuya Minami; Kazuto Kozaka; Azusa Kitao; Norihide Yoneda; Kotaro Yoshida
Journal:  Jpn J Radiol       Date:  2012-10-03       Impact factor: 2.374

7.  Hepatocyte-specific contrast-enhanced MRI findings of focal nodular hyperplasia-like nodules in the liver following chemotherapy in pediatric cancer patients.

Authors:  H Nursun Özcan; Muşturay Karçaaltıncaba; Turgut Seber; Bilgehan Yalçın; Berna Oğuz; Canan Akyüz; Mithat Haliloğlu
Journal:  Diagn Interv Radiol       Date:  2020-07       Impact factor: 2.630

8.  Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI.

Authors:  Adele Taibbi; Giuseppe Brancatelli; Domenica Matranga; Massimo Midiri; Roberto Lagalla; Tommaso Vincenzo Bartolotta
Journal:  Diagn Interv Radiol       Date:  2019-03       Impact factor: 2.630

9.  Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance.

Authors:  Kumi Ozaki; Kenichi Harada; Toru Yamamoto; Hiroyuki Aoyagi; Yasuharu Kaizaki; Jun Yoshikawa
Journal:  Clin J Gastroenterol       Date:  2017-11-07

Review 10.  Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis.

Authors:  Takamichi Murakami; Masakatsu Tsurusaki
Journal:  Liver Cancer       Date:  2014-05       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.